Insiders · VIVS

Keith Murphy

Executive Chairman, Director at VivoSim Labs, INC. (VIVS)

Keith Murphy has filed 12 insider reports with the SEC since March 2021, as director at Matinas BioPharma Holdings, Inc. (MTNB), executive Chairman and director at VivoSim Labs, INC. (VIVS) and director at Kintara Therapeutics, Inc. (HURA). The latest filing, on November 9, 2026, reports grant or award at Matinas BioPharma Holdings, Inc. (MTNB).

Filings
12
Companies
3
Bought on market
None
Sold on market
None

Companies where Keith Murphy is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Matinas BioPharma Holdings, Inc. logo
MTNB
Matinas BioPharma Holdings, Inc.
Directorsince March 2025$0.8557Nov 9, 2026
VivoSim Labs, INC. logo
VIVS
VivoSim Labs, INC.
Executive Chairman, Director26,053$0.1201Jan 30, 2026
Kintara Therapeutics, Inc. logo
HURA
Kintara Therapeutics, Inc.
Director$1.40Sep 23, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Keith Murphy with

Other insiders at the same companies

Questions about Keith Murphy

What is Keith Murphy's role at VivoSim Labs, INC.?
Keith Murphy reports to the SEC as executive Chairman and director at VivoSim Labs, INC. (VIVS), according to the latest filing on January 30, 2026. Keith Murphy has also filed as director at Matinas BioPharma Holdings, Inc. (MTNB) and director at Kintara Therapeutics, Inc. (HURA).
How many shares does Keith Murphy own?
After the latest filing that states it, Keith Murphy directly owned 26,053 shares of VivoSim Labs, INC. (VIVS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Keith Murphy bought or sold stock recently?
No open-market purchases or sales by Keith Murphy are on file. The filings report grant or award.
How do I get alerts when Keith Murphy files?
Follow Keith Murphy on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Keith Murphy filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Keith Murphy (SEC CIK 0001536583). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2021 on. View on SEC EDGAR